Genscript Biotech Corporation (GNNSF)

Genscript Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 6, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,460	2,716	5,398	6,741	9,297	2,842
Market Cap Growth	26.14%	-49.68%	-19.93%	-27.49%	227.16%	-33.34%
Enterprise Value	3,074	2,434	4,867	6,114	8,303	1,914
Last Close Price	1.57	1.27	2.44	2.96	4.55	1.41
PE Ratio	1.11	0.92	-	-	-	-
PS Ratio	4.18	4.57	9.63	10.77	18.97	7.27
PB Ratio	0.78	0.63	2.64	4.95	6.70	3.48
P/TBV Ratio	0.79	0.63	3.94	6.85	9.25	3.30
P/FCF Ratio	26.95	-	-	-	-	-
P/OCF Ratio	15.15	35.90	-	-	-	-
EV/Sales Ratio	3.70	4.09	8.68	9.77	16.94	4.90
EV/EBITDA Ratio	165.29	34.75	58.29	-	-	-
EV/EBIT Ratio	-	262.23	185.81	-	-	-
EV/FCF Ratio	23.94	-	-	-	-	-
Debt / Equity Ratio	0.12	0.17	0.41	0.48	0.30	0.07
Debt / EBITDA Ratio	2.20	8.51	8.59	-	-	-
Debt / FCF Ratio	4.27	-	-	-	-	-
Asset Turnover	0.19	0.14	0.19	0.26	0.27	0.34
Inventory Turnover	8.23	7.64	5.12	6.17	5.46	5.60
Quick Ratio	1.78	2.46	4.50	2.99	3.80	2.85
Current Ratio	1.96	2.72	4.76	3.23	3.97	3.03
Return on Equity (ROE)	-1.94%	-5.46%	9.56%	-31.12%	-47.05%	-47.38%
Return on Assets (ROA)	2.56%	0.13%	0.55%	-11.45%	-12.88%	-10.94%
Return on Invested Capital (ROIC)	4.45%	0.34%	3.34%	-91.80%	-152.50%	-600.56%
Return on Capital Employed (ROCE)	3.70%	0.20%	0.90%	-21.90%	-20.80%	-18.30%
Earnings Yield	89.93%	109.05%	-1.77%	-3.36%	-3.86%	-7.21%
FCF Yield	3.71%	-4.42%	-9.99%	-4.99%	-2.90%	-9.61%
Buyback Yield / Dilution	-4.08%	-3.27%	-0.58%	-3.28%	-6.83%	-2.53%
Total Shareholder Return	-4.08%	-3.27%	-0.58%	-3.28%	-6.83%	-2.53%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.